87 related articles for article (PubMed ID: 30188554)
1. Proanthocyanidin B
Han L; Zhang L; Ma W; Li D; Shi R; Wang M
Food Funct; 2018 Sep; 9(9):4673-4682. PubMed ID: 30188554
[TBL] [Abstract][Full Text] [Related]
2. Barosmin against postprandial hyperglycemia: outputs from computational prediction to functional responses in vitro.
Khanal P; Dwivedi PSR; Patil VS; Shetty A; S A; Aga A; R A; Javaid A; Bhandare VV
J Biomol Struct Dyn; 2024 Jun; 42(9):4489-4505. PubMed ID: 37458811
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of α-glucosidase activity and intestinal glucose transport to assess the
Xu Z; Hileuskaya K; Kraskouski A; Yang Y; Huang Z; Zhao Z
Food Funct; 2024 May; 15(9):4785-4804. PubMed ID: 38511466
[TBL] [Abstract][Full Text] [Related]
4. Acetylation of the polysaccharide from Houttuynia cordata rhizome and their α-glucosidase inhibition mechanism.
He M; Tang S; Xu T; Yuan Y; Wu T; Pan S; Xu X
J Food Sci; 2024 May; 89(5):2672-2683. PubMed ID: 38602052
[TBL] [Abstract][Full Text] [Related]
5. [New European approvals: Carfilzomib with daratumumab and dexamethasone in refractory or relapsed multiple myeloma after a first line of treatment].
Try M; Karlin L
Bull Cancer; 2021 Jun; 108(6):563-565. PubMed ID: 34020786
[No Abstract] [Full Text] [Related]
6. The use of eculizumab in ventilator-dependent myasthenia gravis patients.
Usman U; Chrisman C; Houston D; Haws CC; Wang A; Muley S
Muscle Nerve; 2021 Aug; 64(2):212-215. PubMed ID: 34008175
[TBL] [Abstract][Full Text] [Related]
7. A rare case of refractory and severe duodenal ulcers associated with olmesartan.
Moriya K; Kojima K; Kawaratani H; Noguchi R; Yoshiji H
Gastrointest Endosc; 2021 Sep; 94(3):657-658. PubMed ID: 33965381
[No Abstract] [Full Text] [Related]
8. Switching from Intravenous to Oral Tacrolimus Reduces its Blood Concentration in Paediatric Cancer Patients.
Ujiie H; Nihei S; Nishiya N; Goto S; Asakura Y; Miura S; Hirai D; Endo M; Oyake T; Ito S; Chiba T; Kudo K
Anticancer Res; 2021 May; 41(5):2591-2596. PubMed ID: 33952488
[TBL] [Abstract][Full Text] [Related]
9. Management of Angioimmunoblastic T-Cell Lymphoma (AITL) and other T Follicular Helper Cell lymphomas (TFH PTCL).
Ma H; O'Connor OA; Marchi E
Semin Hematol; 2021 Apr; 58(2):95-102. PubMed ID: 33906727
[TBL] [Abstract][Full Text] [Related]
10. Nivolumab-Induced Polymyalgia Rheumatica in a Patient with Lung Adenocarcinoma.
Kita T; Araya T; Sakai T; Uchida Y; Matsuoka H; Kasahara K
Am J Med Sci; 2021 Sep; 362(3):321-323. PubMed ID: 33905737
[TBL] [Abstract][Full Text] [Related]
11. Use of dexamethasone and a 5-HT3 receptor antagonist with or without aprepitant to prevent chemotherapy-induced nausea and vomiting among patients with lung cancer who are treated with platinum-based chemotherapy: a systematic review and meta-analysis of randomized controlled trials.
He M; Xu R; Liu M; Zhang Y; Yi F; Wei Y; Liu Q; Zhang W
Ann Palliat Med; 2021 Apr; 10(4):4308-4319. PubMed ID: 33894731
[TBL] [Abstract][Full Text] [Related]
12. Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189.
Rodríguez-Abreu D; Powell SF; Hochmair MJ; Gadgeel S; Esteban E; Felip E; Speranza G; De Angelis F; Dómine M; Cheng SY; Bischoff HG; Peled N; Reck M; Hui R; Garon EB; Boyer M; Kurata T; Yang J; Pietanza MC; Souza F; Garassino MC
Ann Oncol; 2021 Jul; 32(7):881-895. PubMed ID: 33894335
[TBL] [Abstract][Full Text] [Related]
13. Randomized Clinical Comparison of the Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent With the Sirolimus-Eluting Orsiro Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT X Trial.
Jakobsen L; Christiansen EH; Freeman P; Kahlert J; Veien K; Maeng M; Raungaard B; Ellert J; Villadsen AB; Kristensen SD; Ahlehoff O; Christensen MK; Terkelsen CJ; Erik Bøtker H; Aaroe J; Thim T; Thuesen L; Aziz A; Eftekhari A; Jensen RV; Støttrup NB; Rasmussen JG; Junker A; Jensen SE; Hansen HS; Jensen LO
Circulation; 2021 Jun; 143(22):2155-2165. PubMed ID: 33823606
[TBL] [Abstract][Full Text] [Related]
14. Afatinib Exerts Immunomodulatory Effects by Targeting the Pyrimidine Biosynthesis Enzyme CAD.
Tu HF; Ko CJ; Lee CT; Lee CF; Lan SW; Lin HH; Lin HY; Ku CC; Lee DY; Chen IC; Chuang YH; Del Caño-Ochoa F; Ramón-Maiques S; Ho CC; Lee MS; Chang GD
Cancer Res; 2021 Jun; 81(12):3270-3282. PubMed ID: 33771897
[TBL] [Abstract][Full Text] [Related]
15. Clinical Experience with Extended-Release Tacrolimus in Older Adult Kidney Transplant Recipients: A Retrospective Cohort Study.
January SE; Hagopian JC; Nesselhauf NM; Progar K; Horwedel TA; Santos RD
Drugs Aging; 2021 May; 38(5):397-406. PubMed ID: 33755934
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory Effect of Green Tea Treatment in Combination with Low-dose Chemotherapy in Elderly Acute Myeloid Leukemia Patients with Myelodysplasia-related Changes.
Calgarotto AK; Longhini AL; Pericole de Souza FV; Duarte ASS; Ferro KP; Santos I; Maso V; Olalla Saad ST; Torello CO
Integr Cancer Ther; 2021; 20():15347354211002647. PubMed ID: 33754891
[TBL] [Abstract][Full Text] [Related]
17. Update in Critical Care 2020.
Khemani RG; Lee JT; Wu D; Schenck EJ; Hayes MM; Kritek PA; Mutlu GM; Gershengorn HB; Coudroy R
Am J Respir Crit Care Med; 2021 May; 203(9):1088-1098. PubMed ID: 33734938
[No Abstract] [Full Text] [Related]
18. Meta-analyses of Results From Randomized Outcome Trials Comparing Cardiovascular Effects of SGLT2is and GLP-1RAs in Asian Versus White Patients With and Without Type 2 Diabetes.
Lee MMY; Ghouri N; McGuire DK; Rutter MK; Sattar N
Diabetes Care; 2021 May; 44(5):1236-1241. PubMed ID: 33707305
[TBL] [Abstract][Full Text] [Related]
19. Safety of concomitant therapy with radium-223 and abiraterone or enzalutamide in a real-world population.
Zhao H; Howard LE; De Hoedt AM; Terris MK; Amling CL; Kane CJ; Cooperberg MR; Aronson WJ; Klaassen Z; Polascik TJ; Vidal AC; Freedland SJ
Prostate; 2021 May; 81(7):390-397. PubMed ID: 33705584
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Clinical Outcome of Ramucirumab for Unresectable Hepatocellular Carcinoma with That of Prior Tyrosine Kinase Inhibitor Therapy.
Amioka K; Kawaoka T; Ogawa Y; Kikukawa C; Naruto K; Yoshikawa Y; Ando Y; Kosaka Y; Uchikawa S; Morio K; Fujino H; Nakahara T; Murakami E; Yamauchi M; Tsuge M; Hiramatsu A; Imamura M; Fukuhara T; Mori N; Takaki S; Tsuji K; Masaki K; Honda Y; Kouno H; Kohno H; Chayama K; Aikata H
Oncology; 2021; 99(5):327-335. PubMed ID: 33677453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
